Systemic adenosine A2A agonist ameliorates ischemic reperfusion injury in the rabbit spinal cord
Systemic adenosine A2A agonist ameliorates ischemic reperfusion injury in the rabbit spinal cord
复制标题
DOI:
10.1016/s0003-4975(01)03057-0
复制
发表时间:
2001-10-01
影响因子:
4.6
通讯作者:
Kern, JA
中科院分区:
文献类型:
--
作者:
Cassada, DC;Gangemi, JJ;Kern, JA
Background. The adenosine A(2A) agonist ATL-146e (4-{3-[6-Amino-9-(5-ethylcarbamoyl-3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}- cyclohexanecarboxylic acid methyl ester) has been shown to prevent reperfusion injury in multiple organ systems through inhibition of activated leukocyte-endothelial interaction. We hypothesized that systemic ATL-146e could reduce spinal cord reperfusion injury after aortic clamping.Methods. Twenty-six rabbits underwent crossclamping of the infrarenal aorta for 45 minutes. One group received intravenous ATL-146e for 3 hours during reperfusion. A second cohort received only vehicle and served as controls. Animals were assessed at 24 and 48 hours using the Tarlov (0 to 5) scoring system for hind limb function. To evaluate neuronal attrition, immunostaining of lumbar spinal cord sections was performed using anti-SMI 33 antibody against neurofilament.Results. Systemic ATL-146e was tolerated without hemodynamic lability. Animals that received ATL-146e had significantly improved neurologic outcomes 24 and 48 hours after spinal cord ischemia (p < 0.001). There was preservation of neuronal architecture in the ventral horn of spinal cord sections from animals receiving ATL-146e compared with control animals.Conclusions. Intravenous ATL-146e given during reperfusion is tolerated without hemodynamic lability, and results in substantially improved spinal cord function after ischemia. by preservation of ventral horn neurons. (C) 2001 by The Society of Thoracic Surgeons.